These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33183953)

  • 1. Differential diagnostic value of
    Zhao J; Wang H
    Acad Radiol; 2022 Feb; 29 Suppl 2():S41-S46. PubMed ID: 33183953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas.
    Uhlén N; Grundberg O; Jacobsson H; Sundin A; Dobra K; Sánchez-Crespo A; Axelsson R; Kölbeck KG
    Clin Nucl Med; 2016 Apr; 41(4):263-7. PubMed ID: 26828139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of
    Tatcı E; Özmen Ö; Öztürk A; Demirağ F
    Mol Imaging Radionucl Ther; 2021 Jun; 30(2):101-106. PubMed ID: 34082511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated FDG-PET/CT imaging is useful in the approach to carcinoid tumors of the lung.
    Stefani A; Franceschetto A; Nesci J; Aramini B; Proli C; Kaleci S; Casolo A; Massi L; Casali C; Morandi U
    J Cardiothorac Surg; 2013 Dec; 8():223. PubMed ID: 24305515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the role of [18F]FDG-PET/CT and [68Ga]DOTATOC-PET/CT in differentiating typical and atypical pulmonary carcinoids.
    Jindal T; Kumar A; Venkitaraman B; Meena M; Kumar R; Malhotra A; Dutta R
    Cancer Imaging; 2011 Jun; 11(1):70-5. PubMed ID: 21697027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of [
    Deleu AL; Laenen A; Decaluwé H; Weynand B; Dooms C; De Wever W; Jentjens S; Goffin K; Vansteenkiste J; Van Laere K; De Leyn P; Nackaerts K; Deroose CM
    EJNMMI Res; 2022 May; 12(1):28. PubMed ID: 35524900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic and prognostic role of combined [
    Albano D; Dondi F; Bauckneht M; Albertelli M; Durmo R; Filice A; Versari A; Morbelli S; Berruti A; Bertagna F
    Eur Radiol; 2023 Jun; 33(6):4167-4177. PubMed ID: 36482218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of 18F-FDG and 68Ga-DOTA-Peptide PET/CT in the evaluation of primary pulmonary carcinoid: A systematic review and meta-analysis.
    Jiang Y; Hou G; Cheng W
    Medicine (Baltimore); 2019 Mar; 98(10):e14769. PubMed ID: 30855482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG PET/CT rarely provides additional information other than primary tumor detection in patients with pulmonary carcinoid tumors.
    Tatci E; Ozmen O; Gokcek A; Biner IU; Ozaydin E; Kaya S; Arslan N
    Ann Thorac Med; 2014 Oct; 9(4):227-31. PubMed ID: 25276242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis value of
    Ye S; Meng S; Bian S; Zhao C; Yang J; Lei W
    BMC Med Imaging; 2023 Feb; 23(1):28. PubMed ID: 36747135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performances of 68Ga-DOTATOC versus 18Fluorodeoxyglucose positron emission tomography in pulmonary carcinoid tumours and interrelationship with histological features.
    Lococo F; Rapicetta C; Mengoli MC; Filice A; Paci M; Di Stefano T; Coruzzi C; Versari A
    Interact Cardiovasc Thorac Surg; 2019 Jun; 28(6):957-960. PubMed ID: 30753507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation Between
    Yu P; Lei J; Xu B; Wang R; Shen Z; Tian J
    Acad Radiol; 2020 May; 27(5):682-688. PubMed ID: 31311773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of 68Ga-DOTATOC PET/CT in initial evaluation of patients with suspected bronchopulmonary carcinoid.
    Venkitaraman B; Karunanithi S; Kumar A; Khilnani GC; Kumar R
    Eur J Nucl Med Mol Imaging; 2014 May; 41(5):856-64. PubMed ID: 24435773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological, Oncogenic, and
    Chen Y; Dong Y; Shi J; Zhao L
    Contrast Media Mol Imaging; 2022; 2022():1926797. PubMed ID: 35821888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of
    Xi XY; Gao W; Gong JN; Guo XJ; Wu JY; Yang YH; Yang MF
    Int J Cardiovasc Imaging; 2019 Jul; 35(7):1395-1403. PubMed ID: 30747369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.
    Krüger S; Buck AK; Blumstein NM; Pauls S; Schelzig H; Kropf C; Schumann C; Mottaghy FM; Hombach V; Reske SN
    J Intern Med; 2006 Dec; 260(6):545-50. PubMed ID: 17116005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: 18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas.
    Lococo F; Rufini V; Treglia G
    Clin Nucl Med; 2017 Jan; 42(1):81. PubMed ID: 27607179
    [No Abstract]   [Full Text] [Related]  

  • 18. 18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas: Reply.
    Sundin A; Uhlén N; Axelsson R
    Clin Nucl Med; 2017 Jan; 42(1):81-82. PubMed ID: 27607160
    [No Abstract]   [Full Text] [Related]  

  • 19.
    Qin C; Shao F; Hu F; Song W; Song Y; Guo J; Lan X
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1083-1093. PubMed ID: 31807883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of (18F)FDG PET/CT and (68Ga)DOTATATE PET/CT imaging methods in terms of detection of histological subtype and related SUVmax values in patients with pulmonary carcinoid tumors.
    Komek H; Can C; Urakçi Z; Kepenek F
    Nucl Med Commun; 2019 May; 40(5):517-524. PubMed ID: 30694875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.